Results 11 to 20 of about 133,861 (300)

Discoid Lupus Erythematosus

open access: yesNew England Journal of Medicine
Red scaly patches develop which leave pigmentation, atrophy and white scars. The lesions are usually asymptomatic but they may present with mild pruritus or sometimes pain within the lesions.
McDaniel B   +3 more
europepmc   +4 more sources

Periorbital discoid lupus: a rare localization in a patient with systemic lupus erythematosus [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2016
A 40-year-old female patient with a 5-year history of systemic lupus erythematosus was referred to our policlinic with complaints of erythema, atrophy, and telangiectasia on the upper eyelids for 8 months.
Ozgur Cakici   +5 more
doaj   +2 more sources

Current Insights Into The Management Of Discoid Lupus Erythematosus

open access: yesClinical, Cosmetic and Investigational Dermatology, 2019
Jaime Company-Quiroga,* Sergio Alique-García,* Alberto Romero-MatéDermatology Department, Fuenlabrada Univesity Hospital, Madrid, Spain*These authors contributed equally to this workCorrespondence: Jaime Company-QuirogaDermatology ...
Company-Quiroga J   +2 more
doaj   +2 more sources

Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE

open access: yesLupus Science and Medicine, 2023
Objective To assess the efficacy of anifrolumab, a type-1 interferon receptor subunit-1 monoclonal antibody, in treating refractory cutaneous lupus erythematosus (CLE) and lupus non-specific mucocutaneous manifestations in patients with systemic lupus ...
Jun Kang, Aaron Bao
doaj   +2 more sources

Anifrolumab for Adolescent Discoid Lupus Erythematosus.

open access: yesJAMA Netw Open, 2023
This case series describes the outcomes among adolescent patients with systemic lupus erythematosus and refractory discoid lupus erythematosus treated with anifrolumab.
Shaw KS   +6 more
europepmc   +2 more sources

Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus

open access: greenJAMA dermatology, 2023
This case series examines the efficacy of anifrolumab as a therapeutic option for patients with lupus erythematosus.
Katharina Shaw   +6 more
openalex   +3 more sources

Different distribution patterns of plasmacytoid dendritic cells in discoid lupus erythematosus and lichen planopilaris demonstrated by CD123 immunostaining, [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2020
Background: Clinical and histological features may overlap between lichen planopilaris-associated and discoid lupus erythematosus-associated scarring alopecia.
Azadeh Rakhshan   +4 more
doaj   +1 more source

Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE).

open access: yesJournal of Drugs in Dermatology, 2023
CITATION Alsukait S, Learned C, Rosmarin D. Open-label phase 2 pilot study of oral tofacitinib in adult subjects with Discoid Lupus Erythematosus (DLE). J Drugs Dermatol. 2023;22(4): 425-427. doi:10.36849/JDD.7098.
S. Alsukait   +2 more
semanticscholar   +1 more source

Dermoscopy of discoid lupus erythematosus

open access: yesIndian Dermatology Online Journal, 2016
Cite this article as: Jha AK, Sonthalia S, Sarkar R. Dermoscopy of discoid lupus erythematosus. Indian Dermatol Online J 2016;7:458. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.
Abhijeet Kumar Jha   +2 more
openaire   +5 more sources

Prognosis of patients with systemic lupus erythematosus and discoid lesions [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2013
BACKGROUND: It has been observed that patients with systemic lupus erythematosus and discoid lesions have a milder systemic disease. OBJECTIVE: To compare the clinical, demographic and autoantibody profile of systemic lupus erythematosus patients ...
Thelma Larocca Skare   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy